Stacked autoencoders as new models for an accurate Alzheimer's disease classification support using resting-state EEG and MRI measurements.

Alzheimer’s Disease (AD) Low-resolution brain electromagnetic tomography (LORETA) Resting State Electroencephalography (rsEEG) Stacked Artificial Neural Networks (ANNs) with Autoencoders

Journal

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
ISSN: 1872-8952
Titre abrégé: Clin Neurophysiol
Pays: Netherlands
ID NLM: 100883319

Informations de publication

Date de publication:
01 2021
Historique:
received: 24 04 2019
revised: 12 08 2020
accepted: 11 09 2020
entrez: 12 1 2021
pubmed: 13 1 2021
medline: 17 7 2021
Statut: ppublish

Résumé

This retrospective and exploratory study tested the accuracy of artificial neural networks (ANNs) at detecting Alzheimer's disease patients with dementia (ADD) based on input variables extracted from resting-state electroencephalogram (rsEEG), structural magnetic resonance imaging (sMRI) or both. For the classification exercise, the ANNs had two architectures that included stacked (autoencoding) hidden layers recreating input data in the output. The classification was based on LORETA source estimates from rsEEG activity recorded with 10-20 montage system (19 electrodes) and standard sMRI variables in 89 ADD and 45 healthy control participants taken from a national database. The ANN with stacked autoencoders and a deep leaning model representing both ADD and control participants showed classification accuracies in discriminating them of 80%, 85%, and 89% using rsEEG, sMRI, and rsEEG + sMRI features, respectively. The two ANNs with stacked autoencoders and a deep leaning model specialized for either ADD or control participants showed classification accuracies of 77%, 83%, and 86% using the same input features. The two architectures of ANNs using stacked (autoencoding) hidden layers consistently reached moderate to high accuracy in the discrimination between ADD and healthy control participants as a function of the rsEEG and sMRI features employed. The present results encourage future multi-centric, prospective and longitudinal cross-validation studies using high resolution EEG techniques and harmonized clinical procedures towards clinical applications of the present ANNs.

Identifiants

pubmed: 33433332
pii: S1388-2457(20)30489-2
doi: 10.1016/j.clinph.2020.09.015
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

232-245

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Raffaele Ferri (R)

Department of Neurology I.C., Oasi Research Institute - IRCCS, Troina, Italy. Electronic address: rferri@oasi.en.it.

Claudio Babiloni (C)

Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy; Hospital San Raffaele Cassino, Cassino (FR), Italy.

Vania Karami (V)

Department of Pharmaceutical Sciences and Health Products, University of Camerino, Camerino, Italy.

Antonio Ivano Triggiani (AI)

Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.

Filippo Carducci (F)

Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy.

Giuseppe Noce (G)

IRCCS SDN, Napoli, Italy.

Roberta Lizio (R)

IRCCS SDN, Napoli, Italy.

Maria T Pascarelli (MT)

Department of Neurology I.C., Oasi Research Institute - IRCCS, Troina, Italy.

Andrea Soricelli (A)

IRCCS SDN, Napoli, Italy; Department of Motor Sciences and Healthiness, University of Naples Parthenope, Naples, Italy.

Francesco Amenta (F)

Department of Pharmaceutical Sciences and Health Products, University of Camerino, Camerino, Italy.

Alessandro Bozzao (A)

Department of Neuroscience, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Andrea Romano (A)

Department of Neuroscience, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Franco Giubilei (F)

Department of Neuroscience, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Claudio Del Percio (C)

Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy.

Fabrizio Stocchi (F)

IRCCS San Raffaele Pisana, Rome, Italy.

Giovanni B Frisoni (GB)

LENITEM (Laboratory of Epidemiology, Neuroimaging and Telemedicine), IRCCS Centro "S. Giovanni di Dio-F.B.F.", Brescia, Italy; Memory Clinic and LANVIE - Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva, Geneva, Switzerland.

Flavio Nobili (F)

Clinica Neurologica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Dipartimento di Neuroscienze, Oftalmologia, Genetica, Riabilitazione e Scienze Materno-infantili (DiNOGMI), Università di Genova, Italy.

Luca Patanè (L)

Dipartimento di Ingegneria, Università degli Studi di Messina, Messina, Italy.

Paolo Arena (P)

Dipartimento di Ingegneria Elettrica, Elettronica e Informatica, University of Catania, Catania, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH